Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by SARAH WHITTLE and SARAH WOODFIELD.
SARAH WHITTLE
Connection Strength
0.412
SARAH WOODFIELD
  1. The novel kinase inhibitor ponatinib is an effective anti-angiogenic agent against neuroblastoma. Invest New Drugs. 2016 12; 34(6):685-692.
    View in: PubMed
    Score: 0.141
  2. A Polymorphism in the FGFR4 Gene Is Associated With Risk of Neuroblastoma and Altered Receptor Degradation. J Pediatr Hematol Oncol. 2016 Mar; 38(2):131-8.
    View in: PubMed
    Score: 0.136
  3. Neuroblastoma patient outcomes, tumor differentiation, and ERK activation are correlated with expression levels of the ubiquitin ligase UBE4B. Genes Cancer. 2016 Jan; 7(1-2):13-26.
    View in: PubMed
    Score: 0.135
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.